Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Antengene, Astrazeneca, Beigene, Biogen, Biontech, Chugai, Codagenix, Cyxone, Daiichi Sankyo, Eisai, Gannex, Henlius, Ix, Open Orphan, Pfizer, Sinovac, Sorrento, Swedish Orphan Biovitrum, Takeda.